Coleen A McNamara Selected Research

Hypertrophy

2/2010

Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Coleen A McNamara Research Topics

Disease

27	Atherosclerosis 07/2022 - 09/2008
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2006
6	Insulin Resistance 01/2020 - 11/2006
5	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 01/2018
4	Obesity 01/2021 - 11/2015
3	Abdominal Aortic Aneurysm 12/2021 - 11/2014
3	Inflammation (Inflammations) 01/2021 - 04/2016
2	Ischemia 01/2022 - 01/2020
2	COVID-19 01/2021 - 01/2021
2	Necrosis 10/2019 - 01/2018
2	Dyslipidemias (Dyslipidemia) 01/2019 - 11/2006
2	Rupture 01/2018 - 11/2014
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2014
2	Hypertension (High Blood Pressure) 01/2018 - 01/2014
2	Vascular Diseases (Vascular Disease) 01/2017 - 10/2005
2	Type 2 Diabetes Mellitus (MODY) 09/2015 - 05/2008
2	Hyperlipidemias (Hyperlipidemia) 01/2014 - 01/2006
2	Vascular System Injuries 01/2006 - 03/2002
1	Aortic Aneurysm (Aneurysm, Aortic) 12/2021
1	Abdominal Obesity 01/2021
1	Infections 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Cytokine Release Syndrome 01/2021
1	Pathologic Constriction (Stenosis) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2020
1	Weight Loss (Weight Reduction) 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2018
1	Diabetes Mellitus 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Neoplasms (Cancer) 11/2016
1	Autoimmune Diseases (Autoimmune Disease) 11/2016
1	Glucose Intolerance 04/2016
1	Glomerulonephritis 01/2014
1	Kidney Diseases (Kidney Disease) 01/2014
1	Chronic Renal Insufficiency 01/2014
1	Hypertrophy 02/2010
1	Hyperplasia 02/2010

Drug/Important Bio-Agent (IBA)

12	Immunoglobulin M (IgM)IBA 01/2022 - 01/2012
11	Apolipoproteins E (ApoE)IBA 01/2021 - 04/2010
8	AntibodiesIBA 01/2021 - 01/2012
7	EpitopesIBA 07/2022 - 12/2013
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2002
6	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2006
5	oxidized low density lipoproteinIBA 01/2022 - 01/2006
4	CytokinesIBA 07/2022 - 09/2008
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 01/2013
3	Immunoglobulin E (IgE)IBA 01/2021 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2015
3	ApolipoproteinsIBA 01/2021 - 01/2014
3	Lipoproteins (Lipoprotein)IBA 01/2020 - 01/2014
3	CholesterolIBA 01/2019 - 05/2008
2	Apolipoproteins B (ApoB)IBA 07/2022 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022 - 12/2021
2	ChemokinesIBA 01/2021 - 01/2014
2	Chemokine ReceptorsIBA 01/2021 - 10/2019
2	1-penicillamyl-Leu(2)- oxytocinIBA 01/2020 - 01/2018
2	AdiponectinIBA 01/2020 - 09/2008
2	CalciumIBA 01/2018 - 01/2014
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2016 - 05/2008
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2022
1	B-Cell Activation Factor ReceptorIBA 12/2021
1	B-Cell Maturation AntigenIBA 12/2021
1	B-Cell Activating FactorIBA 12/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	canakinumab FDA Link 01/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	IsoenzymesIBA 01/2021
1	tesaglitazarIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 10/2019
1	Malondialdehyde (Propanedial)IBA 10/2019
1	NucleotidesIBA 10/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	AutoantibodiesIBA 01/2018
1	AllergensIBA 01/2018
1	HDL LipoproteinsIBA 01/2018
1	OligosaccharidesIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018
1	fibrin fragment D (D-dimer)IBA 01/2018
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	EnzymesIBA 01/2016
1	LDL Receptors (LDL Receptor)IBA 01/2016
1	Insulin (Novolin)FDA Link 09/2015
1	AntigensIBA 07/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 12/2012
1	LipidsIBA 03/2012
1	Oxidants (Oxidizing Agents)IBA 02/2010

Therapy/Procedure

4	Therapeutics 01/2021 - 07/2012
1	Length of Stay 01/2020
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2020